Semax
Human research — investigational use
Research-only / investigational — not FDA approved
Investigational; no FDA-approved drug label is established for this entry. Source: FDA: safety concerns for nominated peptide substances
What it is
A synthetic derivative of an adrenocorticotropic hormone fragment. Source: Human comparative study: semax after ischemic stroke
What it has been studied for
Neurological recovery after ischemic stroke in a comparative study, not cognitive enhancement in healthy people. Source: Human comparative study: semax after ischemic stroke
Mechanism
The clinical study assessed neurological and electrophysiological changes, without establishing a clinical mechanism. Source: Human comparative study: semax after ischemic stroke
Documented dosing
No applicable general-use human dose range, frequency or cycle is documented here. Numbers from other routes, formulations or conditions are not interchangeable.
Pairings & cautions
No evidence-based peptide pairing is specified in this entry.
FDA identifies unresolved safety concerns for this substance. Source: FDA: safety concerns for nominated peptide substances
These are selected considerations, not a complete safety review. Discuss the full source and your medications with your prescriber.
Sources
- Human comparative study: semax after ischemic stroke · Research publication
- FDA: safety concerns for nominated peptide substances · Clinical / regulatory reference